UCF ranked 25th among public universities in the nation for producing patents and 60th in the world, according to a new report released today.
The National Academy of Inventors and the Intellectual Property Owners Association ranks institutions every year based on the number of patents received and filed through the U.S. Patent and Trademark Office. Only the first institution listed on the patent is credited. The 2020 report shows UCF on a steady trajectory of growth, climbing five spots in the world rankings and four nationally.
With 46 patents, UCF was ahead of Carnegie Mellon, Texas A&M and Penn State, and just behind Ohio State (48) and Michigan State (47). The University of California system (597), Massachusetts Institute of Technology (383) and Stanford University (229) took the top three spots. UF ranked the highest among the Florida universities, coming in 11th with 140 patents.
Patents is one measure of our growth and impact, says Elizabeth Klonoff, vice president for Research at UCF. We are strategic about selecting the inventions for patent protection to ensure fiscal responsibility and to maximize the potential of receiving valuable patents. Steady growth of UCFs research base, inventions, patents and industry licensing partnerships feeds our economic ecosystem, which brings not only financial benefit to UCF, but also solidifies our place as a top-tier research institution. Doing our part means we benefit the local community and the society at large by contributing to technological advancements that improve peoples lives and drive the economy.
Some of the 46 patents secured in 2020 have been licensed to companies, which invest in taking the product to market. That means more jobs and often investing in facilities, which all impact the economy. For example, one of UCFs patents for a natural killer-cell therapy against cancer, was licensed to a local company, which was recently acquired by Sanofi, an international pharmaceutical company. Patents are a long-term investment for a university, says Svetlana Shtrom 08MBA, director of UCFs Technology Transfer Office.
Patents themselves do not generate revenue, she says. Licensing patents to industry partners to facilitate transformation of promising research results into valuable products brings true benefit to the university and society. Our data has shown that it takes on average 5 years for 50% of our inventions/technologies to be licensed. It takes an additional 3 to 5 years or longer for companies to commercialize technologies licensed from the university and to begin selling products. The benefit to the university is realized when these products positively impact the well-being of our society through improvements in technology and public health.
Here are some of the inventions and technologies that led to patents in 2020.
Nanoparticle platform stimulates production of natural killer cells
Lead researcher: Associate Professor of Medicine Alicja Copik, College of Medicine
This invention relates to a nanoparticle-based platform for generating potent natural killer (NK) cells for cancer and anti-viral treatment. NK cells are part of the bodys immune system and can kill tumor cells and virus-infected cells. The nanoparticle platform contains agents that stimulate the NK cells to increase their numbers, essentially creating an army of NK cells. This technology is licensed and in development for clinical use.
Combination drug treatment to treat neurological disorders
Lead researcher: Professor of Medicine Kiminobu Sugaya, College of Medicine
This invention relates to a combination therapy to treat neurological disorders such as Alzheimers disease and Parkinsons disease. The treatment is a combination of the drug NBI-18, which increases endogenous neural stem cells, and phenserine, which reduces the production of toxic amyloid plaques in the brain. Mice treated with this combination therapy had increased neural stem cells production and improved performance in memory tasks.
Drug characterization for FDA
Lead Researcher: Associate Professor Debashis Chanda, Nanoscience Technology Center
This invention relates to a system that can accurately identify the chirality (molecular mirror images) of drugs, proteins, DNA and other molecules at lower detection limits than conventional detection systems. The new technology enables pharmaceutical companies to identify both enantiomers (right- and left-hand versions) of a molecule. Pharmacological and toxicological characterization of chiral molecules plays a crucial role in the Food and Drug Administration approval process since some enantiomers can cause toxic or severe side effects.
High Performance Energy Storage
Lead Researcher: Assistant Professor YeonWoong (Eric) Jung, Nanoscience Technology Center
This invention relates to low-cost, non-toxic novel materials that enable next-generation supercapacitors to outperform current state-of-the-art energy storage technologies. The new hybrid core/shell nanowires enable manufacturers to produce flexible supercapacitors with exceptional chargedischarge endurance for portable, lightweight consumer electronic devices.
High-power lasers
Lead researcher: Associate Professor Arkadiy Lyakh, Nanoscience Technology Center
This invention relates to new quantum cascade lasers that provide the ultra-high output power, brightness, and beam quality needed for applications such as hyperspectral imaging, infrared illumination, and military countermeasures that protect aircraft against shoulder-fired heat-seeking missiles.
Track contamination in wetland environments
Lead Researcher: Professor Ni-bin Chang, Civil Engineering Department, College of Engineering & Computer Science
This invention relates to two novel velocimeter devices that assist in the measurement of low-flow velocity and direction of water in both wells and wetland environments. Tracking the movement of nutrients, metals, sediments, and other contamination in slow-moving water is challenging, and these new device designs are easy to use, cost-efficient, have improved accuracy, and are equipped with wireless communication units.
Eco-Friendly Targeted Removal of Fire Ants
Lead researcher: Associate Professor Joshua King, College of Sciences
This invention is a hot-water system for removal of ground dwelling insects, such as fire ants and termites, without the use of pesticides. The system includes a wand connected to a water heating tank and provides large volumes of hot water (approximately heated to boiling temperature, 212oF) to a targeted area. The technology can be used as an alternative to chemical mound treatments or chemical baits in areas unsuitable for pesticide application such as parks and wildlife preserves.
UCF and other public universities in the Florida High TechCorridorregion the University of South Florida and University of Florida together were awarded 309 U.S. utility patents last year, more than 1 times the number of patents granted to other globally recognized centers of innovation, including North Carolinas Research Triangle and the University of Texas System.
This achievement by the Corridor Councils three universities demonstrates the strength of Floridas innovation ecosystem and its role as a catalyst for statewide economic growth, says Florida High Tech Corridor Council CEO Paul Sohl, retired Navy rear admiral.
Read more:
UCF 25th Among Public Universities in the Nation and 60th in the World for Producing Patents - UCF
- SUM Hospital conducts Odishas first stem cell transplantation - The Times of India - April 24th, 2024
- Cancer treatment: What is stem cell therapy, and how does it work? - Moneycontrol - April 24th, 2024
- The murky, unregulated world of anti-ageing stem cell therapy - The Telegraph - April 24th, 2024
- Drug Prototype Promising in Treatment of Pulmonary Disease - Medscape - April 20th, 2024
- Man Paralyzed In Surfing Accident Regains Ability to Walk After Stem Cell Treatment - The Inertia - April 20th, 2024
- Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV - April 20th, 2024
- Stem Cell Treatment Helped A Man Who Was Paralyzed From The Neck Down To Stand On His Own - Bored Panda - April 20th, 2024
- UM, CUHK jointly hold symposium on stem cells and regenerative medicine - gcs.gov.mo - April 20th, 2024
- Paralysed patient now able to walk as stem cell therapy shows promising results - WION - April 15th, 2024
- Andrew Steele Sees Aging as the Root of Disease - Worth - Worth Magazine - April 15th, 2024
- The astonishing effect of stem cell implants - as groundbreaking treatment 'transforms' life for those with brain damage ... - Daily Mail - April 15th, 2024
- Consumer Alert on Regenerative Medicine Products Including Stem Cells - FDA.gov - April 13th, 2024
- This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market - Forbes - April 13th, 2024
- Brain-cell transplants are the newest experimental epilepsy treatment - MIT Technology Review - April 3rd, 2024
- Global Regenerative Medicine Market to Touch Valuation of USD 472.95 Billion by 2032, at 25.86% CAGR: Astute ... - Yahoo Finance - April 1st, 2024
- Explosive Growth Projected for Stem Cell Market, Expected to Surpass $37 Billion by 2030 As Revealed In New... - WhaTech - April 1st, 2024
- Integrating New Therapies With Autologous Stem Cell Transplant in Myeloma - Targeted Oncology - April 1st, 2024
- New tool provides researchers with improved understanding of stem cell aging in the brain - Medical Xpress - March 30th, 2024
- The ISSCR announces 2024 election results - EurekAlert - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Charles River Extends Gene Therapy Alliance with NUS Medicine - Contract Pharma - March 22nd, 2024
- Exciting opportunities in stem cell technology and regenerative biology in Indian healthcare industry - Express Healthcare - March 22nd, 2024
- Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine - Yahoo Finance - March 22nd, 2024
- Opinion: The revolutionary sickle cell therapies - MSN - March 22nd, 2024
- 10 Years of Kansas Regenerative Medicine Center - KSAL - March 22nd, 2024
- BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership - Diagnostic and Interventional Cardiology - March 17th, 2024
- Cynata Therapeutics' breakthrough in regenerative medicine - Finance News Network - March 17th, 2024
- New Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia - GlobeNewswire - March 17th, 2024
- Novel 3D stem cell therapy to treat critical limb ischaemia - Drug Target Review - March 15th, 2024
- Breaking Boundaries: Pharmicell's Bold Vision for Healthcare Transformation and Monumental Growth - The Worldfolio - March 15th, 2024
- CuSTOM Organoid Research Evolving From Tool to Treatment - Research Horizons - Research Horizons - March 15th, 2024
- BioCardia and StemCardia Announce Partnership to Deliver Cell-Gene Therapy for Remuscularization of Heart - Cath Lab Digest - March 15th, 2024
- Calidi Biotherapeutics and City of Hope Announce Funding from the California Institute for Regenerative Medicine ... - Business Wire - March 13th, 2024
- Iron restriction keeps blood stem cells young, researchers find - Phys.org - March 13th, 2024
- Vitamin A could have a key role in both stem cell biology and wound healing: Study - Medical Dialogues - March 9th, 2024
- Trends in Stem Cell Transplantation Refusal for Myeloma Treatment - Targeted Oncology - March 7th, 2024
- Stem Cell Therapy Market (CAGR) of 31.1%, Future of Market Size Emerging Technologies and their Impact on ... - Taiwan News - March 7th, 2024
- This Swedish startup wants to reduce the cost, and controversy, around stem cell production - TechCrunch - March 6th, 2024
- Advancing stem cell therapy: The regulatory process to get to clinical trials - The Economic Times - March 6th, 2024
- Transitioning from traditional surgical methods to the innovative use of stem cells - pharmaphorum - March 6th, 2024
- 'Mini organs' are grown from human stem cells taken during the late stages of pregnancy for the first time - m - Daily Mail - March 6th, 2024
- Stem cell transplant cures man of HIV and leukemia, one of five to achieve full remission - Fox 28 - March 3rd, 2024
- Stem Cell Therapy Market to Boost USD 137.5 Billion by 2034 and Projected to grow at 32.10% CAGR with increasing ... - Yahoo Finance - March 1st, 2024
- Studies expand use of stem cell therapies - WPLG Local 10 - March 1st, 2024
- Innovative therapy targets and destroys leukemia stem cells - News-Medical.Net - February 27th, 2024
- Unlocking the Potential of Stem Cells: The Medical Revolution of the Century - EIN News - February 27th, 2024
- Pelage Pharmaceuticals Announces $16.75M Series A Financing led by GV to Revolutionize Regenerative Medicine ... - Yahoo Finance - February 27th, 2024
- Say Her Name - Henrietta Lacks, The Real Mother Of Stem - Her Campus - February 27th, 2024
- California Man Free of HIV And Cancer in Astonishing Medical Recovery - ScienceAlert - February 25th, 2024
- $93 million for research into improved health for children, young people and the aged, medical devices, mental health ... - Department of Health - February 25th, 2024
- Stem Cells in Regenerative Medicine - PMC - National Center for ... - February 24th, 2024
- The Promise and Reality of Stem Cell Therapy: What You Need to Know - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy: A Beacon of Hope for Patients with Untreatable Conditions - Corporate Wellness Magazine - February 22nd, 2024
- Leading Experts in Stem Cell Therapy: A Global Overview - Corporate Wellness Magazine - February 22nd, 2024
- Can Stem Cells Help Reverse the Effects of Aging? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cell Therapy for Cancer: Hope on the Horizon? - Corporate Wellness Magazine - February 22nd, 2024
- Stem Cells and Autism: A Closer Look at Innovative Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Regrowth and Restoration: The Science Behind Stem Cell Therapy for Hair - Corporate Wellness Magazine - February 22nd, 2024
- Brain Recovery: The Role of Stem Cells in Stroke and Cerebral Palsy Treatments - Corporate Wellness Magazine - February 22nd, 2024
- Turning Back the Clock: The Science of Stem Cells in Anti-Aging - Corporate Wellness Magazine - February 22nd, 2024
- Insights into cellular therapies for cancer treatment - Drug Target Review - February 22nd, 2024
- The Role of Stem Cells in Rheumatoid Arthritis Recovery - Corporate Wellness Magazine - February 22nd, 2024
- Dr Ernesto Romeros vision transforms immunotherapy regenerative medicine into a global leader in stem cell treatment - Khaleej Times - February 22nd, 2024
- World-Renowned Doctors Leading the Way in Stem Cell Research and Treatment - Medical Tourism Magazine - February 20th, 2024
- Choosing the Best: A Guide to America's Premier Stem Cell Therapy Providers - Medical Tourism Magazine - February 20th, 2024
- Navigating Through the Possibilities of Stem Cell Treatment for Eye Disorders - Medical Tourism Magazine - February 20th, 2024
- Global Leaders in Stem Cell Therapy: Where Excellence Meets Innovation - Medical Tourism Magazine - February 20th, 2024
- Excellence in Stem Cell Treatment: How the US is Pioneering Global Healthcare Solutions - Medical Tourism Magazine - February 20th, 2024
- Clarifying Memory Loss Treatments: The Role of Stem Cells - Medical Tourism Magazine - February 20th, 2024
- Battling Inflammation: Stem Cell Therapy for Rheumatoid Arthritis - Medical Tourism Magazine - February 20th, 2024
- Digestive Health and Stem Cells: Treating Ulcerative Colitis and Crohn's Disease - Medical Tourism Magazine - February 20th, 2024
- Top Stem Cell Clinics in the USA: Pioneering Treatments for Chronic Conditions - Medical Tourism Magazine - February 20th, 2024
- Stem Cells and Autism: Understanding the Potential for Innovative Treatments - Medical Tourism Magazine - February 20th, 2024
- Stopping the awakening of sleeping Acute Myeloid Leukaemia stem cells to prevent disease relapse - University of Birmingham - February 20th, 2024
- City of Hope Achieves Ground Breaking Treatment for Blood Cancer and HIV - Medriva - February 18th, 2024
- Regenerative Medicine Market Size to Worth USD 95 Billion by 2032 - InvestorsObserver - February 18th, 2024
- North America Organoids Market Projected to Reach US$ 5.35 Billion by 2030, Riding on a CAGR of 21.5% - GlobeNewswire - February 18th, 2024
- Chinese team tests lung treatment that may be first to reverse COPD damage - South China Morning Post - February 15th, 2024
- Why leukemic stem cells not harmed by chemotherapy begin to grow and produce AML cells after treatment - Medical Xpress - February 15th, 2024
- Regenerative Medicine Market is Expected to Reach $49.0 Billion | MarketsandMarkets - Yahoo Finance - February 15th, 2024
Recent Comments